Skip to main content
Sopharma AD logo

Sopharma AD — Investor Relations & Filings

Ticker · SFA ISIN · BG11SOSOBT18 LEI · 097900BGGW0000048796 BSOBGN Manufacturing
Open in API
Filings indexed 1,488 across all filing types
Latest filing 2021-12-07 Director's Dealing
Country BG Bulgaria
Listing BSOBGN SFA

About Sopharma AD

https://www.sopharmagroup.com/

Sopharma AD is a pharmaceutical company founded in 1933 that specializes in the production, distribution, and export of a wide range of medical products. The company's portfolio includes prescription (Rx) and over-the-counter (OTC) medicines, encompassing both branded and generic drugs. A key area of focus is its traditional plant-based products. Sopharma develops treatments for various conditions, including liver disease, pain management, and smoking cessation. Operating from EU-GMP certified facilities, the company also provides contract manufacturing services and has an established presence in over 40 international markets.

Recent filings

Filing Released Lang Actions
Notification from Alexandar Tchaoushev under Art. 19 of Regulation (EU) No 596/2014 of 6 December 2021.
Director's Dealing Classification · 100% confidence The document explicitly states it is a "NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014". It details transactions executed by a Member of the Board of Directors (Mr. Alexandar Tchaousev) involving the Company's shares. This directly matches the definition for Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length is short, but the content is the primary report itself, not an announcement of a report.
2021-12-07 English
Notification from Alexandar Tchaoushev under Art. 19 of Regulation (EU) No 596/2014 of 6 December 2021.
Director's Dealing Classification · 100% confidence The document is explicitly titled "NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014". It details transactions executed by a Member of the Board of Directors (Mr. Alexandar Tchaoushev) involving the company's shares, including dates, operation type (Buy), number of rights, and unit price. This directly matches the definition for Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades).
2021-12-06 English
Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 3 December 2021.
Director's Dealing Classification · 100% confidence The document is explicitly titled "NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014". It details transactions (Buy operations) executed by an entity ("Telso" AD) related to shares in the Company, involving an individual associated with the company ("Vesela Stoeva"). This directly corresponds to the definition of Director's Dealing (insider trades by directors and executives). The filing type code for this is DIRS.
2021-12-06 English
Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 2 December 2021.
Director's Dealing Classification · 100% confidence The document explicitly states it is a "NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014". It details transactions (Buy operations) executed by an individual related to the company's shares, including dates, number of shares, and unit price. This directly corresponds to the definition of Director's Dealing (insider trades by directors/executives).
2021-12-06 English
Sales revenues for November 2021
Regulatory Filings Classification · 99% confidence The document is a 'Current report' dated December 6, 2021, providing a brief update on sales performance for November 2021 and the eleven months of 2021 compared to the previous year. It contains key performance indicators (KPIs) but is not a comprehensive financial statement (like 10-K or IR) nor a full transcript (CT). It is a short, periodic operational update. This type of brief, periodic operational or sales update, especially when issued as a 'Current report' outside of the standard quarterly/annual reporting cycle, often falls under general regulatory announcements or interim updates. Given the options, it is too brief and focused on operational metrics rather than comprehensive financials to be an Interim Report (IR). It is best classified as a general Regulatory Filing (RNS) as it is a mandatory disclosure of material information that doesn't fit a more specific category like ER (Earnings Release, which usually contains more structured results) or DIV/NAV/DVA.
2021-12-06 English
Treasury shares
Transaction in Own Shares Classification · 100% confidence The document is a 'Current report' dated December 6, 2021, specifically titled 'Treasury shares'. The text explicitly states that the Company 'bought 143 533 own shares' and details the total number of treasury shares held afterward. This action directly corresponds to the definition of a company buying back or selling its own shares, which maps to the 'Transaction in Own Shares' category (POS). The document length is very short (622 chars), but it contains the substantive details of the transaction, not just an announcement that a report is available, thus making POS a more specific fit than RPA or RNS.
2021-12-06 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.